Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy-Reference-Cited by-同舟云学术

Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy

Published:2019 Issue:7 Volume:7 Page:2640-2651
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Mei Yeling¹²³⁴^ORCID,Wang Ruibo⁵⁶⁷⁸^ORCID,Jiang Wei¹²³⁴,Bo Yang⁵⁶⁷⁸,Zhang Tengfei¹²³⁴,Yu Junlin¹²³⁴,Cheng Ming⁹²³⁴,Wu Yunzi¹²³⁴,Cheng Jianjun⁵⁶⁷⁸^ORCID,Ma Wang¹²³⁴

Affiliation:

1. Department of Oncology

2. The First Affiliated Hospital of Zhengzhou University

3. Zhengzhou 450052

4. China

5. Department of Materials Science and Engineering

6. University of Illinois at Urbana-Champaign

7. Urbana

8. USA

9. Department of Medical information

Abstract

The recent progress in nanomaterial mediated delivery of siRNA for cancer immunotherapy.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2019/BM/C9BM00214F

Reference86 articles.

1. Nanomaterials for cancer immunotherapy

2. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors

3. Dendritic Cell-Based Immunotherapy for Solid Tumors

4. Cancer immunotherapy targeting neoantigens

5. Phase I study of BMS-663513, a fully human anti-CD137 agonist monoclonal antibody, in patients (pts) with advanced cancer (CA)

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives;Chemical Engineering Journal;2024-04

2. Efficient polymeric nanoparticles for RNAi in macrophage reveal complex effects on polarization markers upon knockdown of STAT3/STAT6;European Journal of Pharmaceutics and Biopharmaceutics;2024-04

3. Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy;Advanced Materials;2024-03-04

4. Advances and applications of nanoparticles in cancer therapy;MedComm – Oncology;2024-03

5. Advances in non-viral mRNA delivery to the spleen;Biomaterials Science;2024